This framework was widely accepted until the 1990s when biopsy studies reported consistent inflammatory features across asthma patients (11–13) including elevations in newly identified type-2 (T2) cytokines like interleukin (IL)-4, IL-5, and IL-13 (14, 15). This evidence concerns the gene IL4 and asthma.